Showing results (1-10 of 316) with videos related to
Sort By:
Pageof 32
Seminars in Surgical Oncology|May 11, 2000
Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancerP O Chappuis, V Nethercot, W D FoulkesClinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1995
Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testingW D Foulkes, S A NarodAnnals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
The influence of familial and hereditary factors on the prognosis of breast cancerP O Chappuis, J Rosenblatt, W D FoulkesCancer Investigation|April 9, 2001
The role of genetic factors in the etiology of pancreatic adenocarcinoma: an updateP O Chappuis, P Ghadirian, W D FoulkesJournal of Mammary Gland Biology and Neoplasia|May 16, 2002
The contribution of inherited factors to the clinicopathological features and behavior of breast cancerW D Foulkes, J Rosenblatt, P O ChappuisJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancerP O Chappuis, L Kapusta, L R Bégin, et al.Cancer Research|May 19, 2001
TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distributionM S Greenblatt, P O Chappuis, J P Bond, et al.Clinical Genetics|April 27, 2000
A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genesG Kuperstein, W D Foulkes, P Ghadirian, et al.The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based studyT Pal, F D Vogl, P O Chappuis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcomeW D Foulkes, P O Chappuis, N Wong, et al.Pageof 32